What are OptimizeRx's profit margins?

OptimizeRx (OPRX) runs a 70.0% gross margin and a 13.2% operating margin, with a 6.4% net margin.

Where do OptimizeRx's ratios come from?

Every ratio is computed from OptimizeRx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

OptimizeRx OPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	70%+2.8pp	67.3%+1.9pp	65.3%+0.9pp	64.4%+8.5pp	55.9%+15.6pp
Operating margin	13.2%+2.5pp	10.7%—	——	——	——
Net margin	6.4%+1.7pp	4.7%+4.7pp	0%+9.5pp	-9.4%+10.7pp	-20.1%+16.6pp
EBITDA margin	17.2%+2.6pp	14.7%—	——	——	——
Free cash flow margin	13.4%-3.7pp	17%+6.3pp	10.7%+0.9pp	9.9%+1.4pp	8.5%-0.2pp
Returns
Return on equity	5.6%+1.4pp	4.2%+4.2pp	0%+8.2pp	-8.2%+4.7pp	-12.9%+3.6pp
Return on assets	4.1%+1.1pp	2.9%+2.9pp	0%+5.8pp	-5.8%+3.2pp	-9%+2.4pp
Return on invested capital	7.6%+1.2pp	6.4%—	——	——	——
Efficiency
Asset turnover	0.6×0.0×	0.6×0.0×	0.7×0.0×	0.6×+0.2×	0.4×+0.1×
Liquidity
Current ratio	5.4×+2.3×	3×0.0×	3×+0.5×	2.6×-0.2×	2.8×-0.1×
Quick ratio	5.4×+2.3×	3×0.0×	3×+0.5×	2.6×-0.2×	2.8×-0.1×
Cash ratio	1.9×+0.8×	1.1×0.0×	1.1×+0.3×	0.8×-0.1×	0.9×+0.2×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.3×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	0.2×0.0×	0.2×—	——	——	——
Interest coverage	2.8×+0.5×	2.2×—	——	——	——
Per Share
Book value per share	$6.91+2.3%	$6.75+7.5%	$6.28+0.2%	$6.27-0.3%	$6.29-1.6%
Valuation
Market capitalization	$107.34M-54.1%	$228.53M-40.0%	$380.58M+59.5%	$238.59M+49.0%	$160.13M+78.9%
Enterprise value	$110.88M-55.0%	$231.27M-40.6%	$389.67M+55.3%	$250.98M+42.3%	$176.35M+61.3%
Price / earnings	15.7×—	44.5×-11,149×	11,193.6×—	——	——
Price / sales	1×-1.2×	2.1×-1.4×	3.5×+1.2×	2.3×+0.2×	2.1×+0.5×
Price / book	0.8×-1.1×	1.8×-1.3×	3.1×+1.1×	2×+0.6×	1.4×+0.6×
EV / EBITDA	6×—	14.4×—	——	——	——
EV / sales	1×-1.3×	2.1×-1.4×	3.6×+1.2×	2.4×+0.1×	2.3×+0.3×
Free cash flow yield	13.4%+8.9pp	8.2%+5.1pp	3.1%-1.2pp	4.3%+0.3pp	4.1%-1.3pp
Earnings yield	6.4%+10.6pp	2.2%+2.2pp	0%+4.1pp	-4.1%+5.5pp	-9.6%+12.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about OptimizeRx.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are OptimizeRx's profit margins?: OptimizeRx (OPRX) runs a 70.0% gross margin and a 13.2% operating margin, with a 6.4% net margin.
Where do OptimizeRx's ratios come from?: Every ratio is computed from OptimizeRx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.